Volume 133, Issue 4, Pages (October 2007)

Slides:



Advertisements
Similar presentations
Postinfectious Irritable Bowel Syndrome
Advertisements

Effect of Linaclotide on Severe Abdominal Symptoms in Patients With Irritable Bowel Syndrome With Constipation  Satish S.C. Rao, Eamonn M.M. Quigley,
Volume 149, Issue 6, Pages e2 (November 2015)
Volume 145, Issue 4, Pages (October 2013)
Diet as a Therapy for Irritable Bowel Syndrome: Progress at Last
Volume 134, Issue 7, Pages (June 2008)
Effect of Linaclotide on Severe Abdominal Symptoms in Patients With Irritable Bowel Syndrome With Constipation  Satish S.C. Rao, Eamonn M.M. Quigley,
Prevalence, Characteristics, and Impact of Bloating Symptoms in Patients With Irritable Bowel Syndrome  Yehuda Ringel, Rachel E. Williams, Linda Kalilani,
Volume 128, Issue 3, Pages (March 2005)
Charles D. Gerson, Mary-Joan Gerson 
Volume 133, Issue 2, Pages (August 2007)
Christoph Lübbert, Babett Holler  Gastroenterology 
Covering the Cover Gastroenterology
Is rectal pain sensitivity a biological marker for irritable bowel syndrome: Psychological influences on pain perception  William E. Whitehead, Olafur.
Role of Colonic Fermentation in the Perception of Colonic Distention in Irritable Bowel Syndrome and Functional Bloating  Michele Di Stefano, Emanuela.
Volume 154, Issue 3, Pages e2 (February 2018)
Volume 133, Issue 5, Pages (November 2007)
Treatment of Esophageal (Noncardiac) Chest Pain: An Expert Review
Novel Evidence for Hypersensitivity of Visceral Sensory Neural Circuitry in Irritable Bowel Syndrome Patients  Adeyemi Lawal, Mark Kern, Harjot Sidhu,
Prevalence of Irritable Bowel Syndrome–type Symptoms in Patients With Celiac Disease: A Meta-analysis  Anita Sainsbury, David S. Sanders, Alexander C.
Volume 141, Issue 5, Pages (November 2011)
Volume 149, Issue 6, Pages e2 (November 2015)
A Diet Low in Fermentable Oligo-, Di-, and Monosaccharides and Polyols Improves Quality of Life and Reduces Activity Impairment in Patients With Irritable.
Volume 154, Issue 5, Pages (April 2018)
Clinical Challenges and Images in GI
Volume 149, Issue 6, Pages e2 (November 2015)
Volume 150, Issue 4, Pages (April 2016)
Issue Highlights Clinical Gastroenterology and Hepatology
Prospective Study of Motor, Sensory, Psychologic, and Autonomic Functions in Patients With Irritable Bowel Syndrome  Michael Camilleri, Sanna McKinzie,
Volume 150, Issue 4, Pages (April 2016)
Volume 133, Issue 2, Pages (August 2007)
Lactulose Challenge Determines Visceral Sensitivity and Severity of Symptoms in Patients With Irritable Bowel Syndrome  Boris Le Nevé, Rémi Brazeilles,
Volume 139, Issue 4, Pages e4 (October 2010)
Volume 151, Issue 6, Pages (December 2016)
A Comprehensive Self-Management Irritable Bowel Syndrome Program Produces Sustainable Changes in Behavior After 1 Year  Jasmine K. Zia, Pamela Barney,
Effects of 5-Hydroxytryptamine (Serotonin) Type 3 Antagonists on Symptom Relief and Constipation in Nonconstipated Irritable Bowel Syndrome: A Systematic.
Dietary Triggers of Abdominal Symptoms in Patients With Irritable Bowel Syndrome: Randomized Placebo-Controlled Evidence  Susan J. Shepherd, Francis C.
Effects of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation or Chronic Constipation: A Meta-analysis  Elizabeth J. Videlock, Vivian.
Volume 153, Issue 4, Pages (October 2017)
Kara Bradford, Wendy Shih, Elizabeth J. Videlock, Angela P
Bowel Urgency in Patients With Irritable Bowel Syndrome
Ashwin N. Ananthakrishnan, David Lieberman  Gastroenterology 
Coping Skills Are Associated With Gastrointestinal Symptom Severity and Somatization in Patients With Irritable Bowel Syndrome  Katarina Wilpart, Hans.
Rebecca M. Lovell, Alexander C. Ford 
Volume 145, Issue 3, Pages (September 2013)
Volume 134, Issue 7, Pages (June 2008)
Issue Highlights Clinical Gastroenterology and Hepatology
Effects of Different Coping Strategies on Physical and Mental Health of Patients With Irritable Bowel Syndrome  Lilian Dindo, PhD  Clinical Gastroenterology.
Issue Highlights Clinical Gastroenterology and Hepatology
Health-Related Quality of Life in Patients Attending a Gastroenterology Outpatient Clinic: Functional Disorders Versus Organic Diseases  Magnus Simrén,
Immune Activation in Patients With Irritable Bowel Syndrome
Pathophysiology and treatment of functional dyspepsia
The Dawning of a New Editorial Board for Gastroenterology
Clinical Challenges and Images in GI
New Epidemiologic Evidence on Functional Dyspepsia Subgroups and Their Relationship to Psychosocial Dysfunction  Lukas Van Oudenhove, Jan Tack  Gastroenterology 
Risk of Irritable Bowel Syndrome After an Episode of Bacterial Gastroenteritis in General Practice: Influence of Comorbidities  Ana Ruigómez, Luis Alberto.
The selective serotonin reuptake inhibitor fluoxetine does not change rectal sensitivity and symptoms in patients with irritable bowel syndrome: A double.
Volume 151, Issue 4, Pages (October 2016)
Volume 144, Issue 3, Pages (March 2013)
Volume 122, Issue 7, Pages (June 2002)
Severe irritable bowel and functional abdominal pain syndromes: Managing the patient and health care costs  George F. Longstreth, Douglas A. Drossman 
Postinfectious Irritable Bowel Syndrome
Rectal hyperreactivity to distention in patients with irritable bowel syndrome: role of distention rate  Maura Corsetti, Bruno Cesana, Sherrie Bhoori,
Quantitative Meta-analysis Identifies Brain Regions Activated During Rectal Distension in Irritable Bowel Syndrome  Kirsten Tillisch, Emeran A. Mayer,
Electronic Clinical Challenges and Images in GI
Volume 139, Issue 1, Pages (July 2010)
Electronic Clinical Challenges and Images in GI
Bowel Urgency in Patients With Irritable Bowel Syndrome
Self-Administered Cognitive Behavior Therapy for Moderate to Severe Irritable Bowel Syndrome: Clinical Efficacy, Tolerability, Feasibility  Jeffrey M.
Covering the Cover Gastroenterology
Presentation transcript:

Volume 133, Issue 4, Pages 1113-1123 (October 2007) Altered Rectal Perception in Irritable Bowel Syndrome Is Associated With Symptom Severity  Iris Posserud, Alma Syrous, Lina Lindström, Jan Tack, Hasse Abrahamsson, Magnus Simrén  Gastroenterology  Volume 133, Issue 4, Pages 1113-1123 (October 2007) DOI: 10.1053/j.gastro.2007.07.024 Copyright © 2007 AGA Institute Terms and Conditions

Figure 1 The individual symptoms included in the GSRS-IBS divided into 5 different domains. The symptoms are scored on a 7-grade Likert scale ranging from ”no discomfort” to ”very severe discomfort.”30 Gastroenterology 2007 133, 1113-1123DOI: (10.1053/j.gastro.2007.07.024) Copyright © 2007 AGA Institute Terms and Conditions

Figure 2 Box-and-whisker plots (extreme values and outliers not shown) demonstrating the data distribution in control subjects and patients with IBS of (A) the rectal discomfort threshold (mm Hg), (B) the rectal pain threshold (mm Hg), (C) VAS for unpleasantness (mm; mean of the first 4 distentions), and (D) the viscerosomatic referral area for nonpainful sensations (cm2). ****P < .0001. Gastroenterology 2007 133, 1113-1123DOI: (10.1053/j.gastro.2007.07.024) Copyright © 2007 AGA Institute Terms and Conditions

Figure 3 Sensory thresholds in female and male patients with IBS. *P < .05; **P < .01. Gastroenterology 2007 133, 1113-1123DOI: (10.1053/j.gastro.2007.07.024) Copyright © 2007 AGA Institute Terms and Conditions

Figure 4 The proportion having at least moderate symptom severity (mean scores on GSRS-IBS domains ≥4) in the groups with altered vs normal rectal perception, as well as the proportion of patients having clinically significant anxiety and depression according to HAD (score on HAD anxiety or HAD depression ≥11). Shown also is the proportion of patients in the respective groups having a GSRS mean total score ≥4, meaning at least moderate GI symptom severity overall (total GI symptoms [sx]). *P < .05; **P < .01; ****P < .0001. Gastroenterology 2007 133, 1113-1123DOI: (10.1053/j.gastro.2007.07.024) Copyright © 2007 AGA Institute Terms and Conditions